Charlebois ED - Search Results

1

Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization.

Carrico AW, Riley ED, Johnson MO, Charlebois ED, Neilands TB, Remien RH, Lightfoot MA, Steward WT, Weinhardt LS, Kelly JA, Rotheram-Borus MJ, Morin SF, Chesney MA. Carrico AW, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):146-50. doi: 10.1097/QAI.0b013e318201df63. J Acquir Immune Defic Syndr. 2011. PMID: 21116186 Free PMC article. Clinical Trial.

2

Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease.

Stanley HD, Charlebois E, Harb G, Jacobson MA. Stanley HD, et al. J Acquir Immune Defic Syndr (1988). 1994 Mar;7(3):272-8. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8106966

3

Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura.

Northfelt DW, Charlebois ED, Mirda MI, Child C, Kaplan LD, Abrams DI. Northfelt DW, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):45-50. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 8548345 Clinical Trial.

4

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. AIDS. 2000 Mar 10;14(4):357-66. doi: 10.1097/00002030-200003100-00008. AIDS. 2000. PMID: 10770537

5

Provider assessment of adherence to HIV antiretroviral therapy.

Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):435-42. doi: 10.1097/00126334-200104150-00005. J Acquir Immune Defic Syndr. 2001. PMID: 11391162

6

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. AIDS. 2001 Jun 15;15(9):1181-3. doi: 10.1097/00002030-200106150-00015. AIDS. 2001. PMID: 11416722 No abstract available.

7

Expanding access to early HIV care: new challenges for federal health policy.

Morin SF, Charlebois ED. Morin SF, et al. Among authors: charlebois ed. AIDS Public Policy J. 2000 Summer;15(2):65-74. AIDS Public Policy J. 2000. PMID: 11519368

8

Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project.

Johnson MO, Catz SL, Remien RH, Rotheram-Borus MJ, Morin SF, Charlebois E, Gore-Felton C, Goldsten RB, Wolfe H, Lightfoot M, Chesney MA; NIMH Healthy Living Project Team. Johnson MO, et al. AIDS Patient Care STDS. 2003 Dec;17(12):645-56. doi: 10.1089/108729103771928708. AIDS Patient Care STDS. 2003. PMID: 14746658

9

Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.

Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Porco TC, et al. AIDS. 2004 Jan 2;18(1):81-8. doi: 10.1097/00002030-200401020-00010. AIDS. 2004. PMID: 15090833 Free PMC article.

10

Are untimed antiretroviral drug levels useful predictors of adherence behavior?

Liechty CA, Alexander CS, Harrigan PR, Guzman JD, Charlebois ED, Moss AR, Bangsberg DR. Liechty CA, et al. Among authors: charlebois ed. AIDS. 2004 Jan 2;18(1):127-9. doi: 10.1097/00002030-200401020-00017. AIDS. 2004. PMID: 15090840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters